<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53456">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01658631</url>
  </required_header>
  <id_info>
    <org_study_id>2010/42</org_study_id>
    <nct_id>NCT01658631</nct_id>
  </id_info>
  <brief_title>Evaluation of Nexfin During Anesthesia and in Intensive Care (NexfinEval)</brief_title>
  <official_title>Evaluation of Nexfin During Induction of General Anesthesia and in Intensive Care During a Passive Legs Raising Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the non invasive measurement of arterial pressure
      (Nexfin monitor)with the invasive measurement of arterial pressure (radial artery catheter)

        -  during induction  of general anesthesia,

        -  during a leg raising test in the Intensive Care Unit
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Arterial pressure measurement</measure>
    <time_frame>Blood pressure will be followed for the duration of induction of anesthesia, an expected average of 20 minutes, or for the passive legs raising test, an expected average of 20 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Anesthesia</arm_group_label>
    <description>Arterial pressure measurement using Nexfin (a noninvasive finger cuff system) during the induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive Care Unit patients</arm_group_label>
    <description>Arterial pressure measurement using Nexfin (a noninvasive finger cuff system) during a passive legs raising test</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>arterial pressure measurement (Nexfin, a noninvasive finger cuff system)</intervention_name>
    <arm_group_label>Anesthesia</arm_group_label>
    <arm_group_label>Intensive Care Unit patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing major surgery with the need for an invasive blood pressure measurement
        and ICU patients requiring a passive legs raising test
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18

          -  ASA II, III or IV

          -  weight between 40 and 180 kg; BMI &lt; 35

          -  normal Allen's test and/or hand Doppler examination.

        Exclusion Criteria:

          -  cardiac arrhythmias,

          -  history of vascular surgery or vascular implant in the upper limb

          -  Raynaud disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc Fischler, MD</last_name>
    <phone>46252442</phone>
    <phone_ext>00331</phone_ext>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut Mutualiste Montsouris</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Lamer, MD</last_name>
      <phone>56616263</phone>
      <phone_ext>00331</phone_ext>
      <email>christian.lamer@imm.fr</email>
    </contact>
    <investigator>
      <last_name>Christian Lamer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Fischler, MD</last_name>
      <phone>46252442</phone>
      <phone_ext>00331</phone_ext>
      <email>m.fischler@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>January 12, 2014</lastchanged_date>
  <firstreceived_date>August 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
